Bayer Healthcare has chosen the award-winning Burgopak Slider for its new treatment for erectile dysfunction, Levitra 10-mg ODT. This is the third product line that Bayer has chosen to use the Burgopak Slider for, following Rennie Ice and Rennie Peppermint, their heartburn and indigestion products.
Thomas Proske, global brand manager for Levitra® at Bayer Healthcare says: “We chose the Burgopak design for our new Levitra formulation because it’s pocket-friendly, discreet, and gives the product a playful edge over its competitors. While it is patient safe and compliant, it also looks stylish and will appeal to our customers.”
Bayer’s Levitra® 10 mg ODT will be available in France, Chile, Austria, and Hungary during November/December 2010, with further countries to follow over the next six months. Tim Clarke, CEO of Burgopak Healthcare and Technology, says: “The innovative packaging design adds significant value to the brand as it’s slick, unique, and appealing to consumers while supporting patient safety and compliance. In a highly competitive market, it offers differentiation and we’re delighted to continue working with Bayer.”
In 2008, the first automated Burgopak Slider was launched into the pharmaceutical market, offering companies a unique operating system that supports patient safety and compliance. Robust, portable, and user-friendly, these innovative pharmaceutical packs incorporate the Burgopak patented sliding mechanism that keeps the patient information booklet, the blisters containing the medication, and the branded outer carton conveniently connected at all times. For more, visit www.burgopak.com.
Did you enjoy this article? Click here to subscribe to the magazine.